This Biotech Stock Is Surging 80%. Gilead Sciences Has Agreed to Buy It.
Barrons·2026-02-23 19:34

并购交易公告 - 吉利德科学同意以总价78亿美元收购Arcellx公司 [1] - 该交易于周一宣布 [1] 市场反应 - Arcellx公司股价在周一开盘前飙升78% [1]

This Biotech Stock Is Surging 80%. Gilead Sciences Has Agreed to Buy It. - Reportify